Cargando…

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a subset of breast cancer with an adverse prognosis and significant tumor heterogeneity. Here, we extract quantitative radiomic features from contrast-enhanced magnetic resonance images to construct a breast cancer radiomic dataset (n = 860) and a TNBC radioge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Lin, You, Chao, Xiao, Yi, Wang, He, Su, Guan-Hua, Xia, Bing-Qing, Zheng, Ren-Cheng, Zhang, Dan-Dan, Jiang, Yi-Zhou, Gu, Ya-Jia, Shao, Zhi-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381418/ https://www.ncbi.nlm.nih.gov/pubmed/35858585 http://dx.doi.org/10.1016/j.xcrm.2022.100694

Ejemplares similares

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets
por: Su, Guan-Hua, et al.
Publicado: (2023)

Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targets
por: Zhang, Ying, et al.
Publicado: (2022)

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer
por: Su, Guan-Hua, et al.
Publicado: (2022)

Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer
por: Fan, Ming, et al.
Publicado: (2020)

Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
por: Wang, Yi, et al.
Publicado: (2023)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer
por: Zhou, Yi-Fan, et al.
Publicado: (2021)

Radiogenomic analysis of cellular tumor-stroma heterogeneity as a prognostic predictor in breast cancer
por: Fan, Ming, et al.
Publicado: (2023)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
por: Ding, Jia-Han, et al.
Publicado: (2022)

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers
por: Wang, Lei, et al.
Publicado: (2020)

A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma
por: Gao, Jiahao, et al.
Publicado: (2022)

Radiogenomics of lung cancer
por: Wong, Chi Wah, et al.
Publicado: (2020)

Radiogenomics in Colorectal Cancer
por: Badic, Bogdan, et al.
Publicado: (2021)

Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer
por: Chen, Yu-Hung, et al.
Publicado: (2023)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Radiomics and radiogenomics for precision radiotherapy
por: Wu, Jia, et al.
Publicado: (2018)

Radiogenomics and Radiomics in Liver Cancers
por: Saini, Aman, et al.
Publicado: (2018)

Precision Medicine in Radiomics and Radiogenomics
por: Monti, Serena
Publicado: (2022)

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2021)

Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer
por: Jian, Dan, et al.
Publicado: (2022)

Radiomics and radiogenomics of primary liver cancers
por: Jeong, Woo Kyoung, et al.
Publicado: (2019)

Breast Ultrasound Microvascular Imaging and Radiogenomics
por: Park, Ah Young, et al.
Publicado: (2021)

Fused feature signatures to probe tumour radiogenomics relationships
por: Xia, Tian, et al.
Publicado: (2022)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

CT-based radiogenomic analysis dissects intratumor heterogeneity and predicts prognosis of colorectal cancer: a multi-institutional retrospective study
por: Zhong, Min-Er, et al.
Publicado: (2022)

SYTL4 downregulates microtubule stability and confers paclitaxel resistance in triple-negative breast cancer
por: Liu, Xi-Yu, et al.
Publicado: (2020)

MRI Radiogenomics in Precision Oncology: New Diagnosis and Treatment Method
por: Yin, Xiao-Xia, et al.
Publicado: (2022)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Computed Tomography Imaging-Based Radiogenomics Analysis Reveals Hypoxia Patterns and Immunological Characteristics in Ovarian Cancer
por: Feng, Songwei, et al.
Publicado: (2022)

Contrast-Enhanced Computed Tomography–Based Radiogenomics Analysis for Predicting Prognosis in Gastric Cancer
por: Liu, Han, et al.
Publicado: (2022)

Radiogenomics-based cancer prognosis in colorectal cancer
por: Badic, Bogdan, et al.
Publicado: (2019)

Integrative radiogenomic analysis for multicentric radiophenotype in glioblastoma
por: Kong, Doo-Sik, et al.
Publicado: (2016)

Combining molecular and imaging metrics in cancer: radiogenomics
por: Lo Gullo, Roberto, et al.
Publicado: (2020)

Radiomics and radiogenomics in gliomas: a contemporary update
por: Singh, Gagandeep, et al.
Publicado: (2021)

The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology
por: Shui, Lin, et al.
Publicado: (2021)

Radiogenomic analysis of vascular endothelial growth factor in patients with diffuse gliomas
por: Sun, Zhiyan, et al.
Publicado: (2019)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Unraveling Heterogeneity of Tumor Cells and Microenvironment and Its Clinical Implications for Triple Negative Breast Cancer
por: Jiang, Ke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bavtm8m3l08p1jqscrhfu82666